BIODEXA PHARMACEUTICALS-ADR (BDRX) Stock Cash Flow
NASDAQ:BDRX - Nasdaq - US59564R8079 - ADR - Currency: USD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.82M | -7.08M | -7.66M | -5.46M | -22.19M | |||
| Depreciation Amortization | 276.00K | 283.00K | 343.00K | 403.00K | 1.22M | |||
| Change In Working Capital | -281.00K | 796.00K | 1.20M | 540.00K | 396.00K | |||
| Interest Paid | N/A | 13.00K | 18.00K | 15.00K | 34.00K | |||
| Taxes Paid | N/A | -845.00K | -678.00K | -1.16M | -1.95M | |||
| Other non cash items | -928.00K | -826.00K | -933.00K | -1.49M | 11.28M | |||
| OPERATING CASH FLOW | -7.75M | -6.83M | -7.05M | -6.01M | -9.30M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.11M | -263.00K | -62.00K | -320.00K | -209.00K | |||
| Other Investing Activity | 72.00K | -2.00K | -158.00K | 42.00K | 2.78M | |||
| INVESTING CASH FLOW | -1.04M | -265.00K | -220.00K | -278.00K | 2.57M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -186.00K | -188.00K | -178.00K | -215.00K | -6.67M | |||
| Stock Issued/Repurchased | 8.81M | 10.43M | 243.00K | 9.04M | 9.74M | |||
| Other Financing Activity | N/A | -13.00K | -18.00K | -15.00K | 11.00K | |||
| FINANCING CASH FLOW | 8.62M | 10.23M | 47.00K | 8.80M | 3.08M | |||
| Exchange Rate Effect | N/A | 0.00 | 0.00 | -8.00K | 261.00K | |||
| CHANGE IN CASH | -172.00K | 3.14M | -7.22M | 2.51M | -3.38M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -7.75M | -6.83M | -7.05M | -6.01M | -9.30M | |||
| Capital Expenditure | -1.11M | -263.00K | -62.00K | -320.00K | -209.00K | |||
| FREE CASH FLOW | -8.86M | -7.09M | -7.11M | -6.33M | -9.51M | |||
All data in GBP